Who
William Hartzel
SVP, Bioservices
Company insider
Files Form 4 as: SVP, Bioservices, Emergent BioSolutions.
In numbers
- Trades disclosed
- 27
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 11 Nov 2023
- Last trade
- 8 Jun 2026
- Last filed
- 10 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Jun 2026filed 10 Jun 2026 | EBS Emergent BioSolutionsBiotechnology | SEC FORM 4 Code F | $14K1,741 at $8.00 | filing |
| 8 Jun 2026filed 10 Jun 2026 | EBS Emergent BioSolutionsBiotechnology | SEC FORM 4 Code F | $14K1,741 at $8.00 | filing |
| 29 Apr 2026filed 1 May 2026 | EBS Emergent BioSolutionsBiotechnology | SEC FORM 4 Code A | —100,111 at $0.00 | filing |
| 29 Apr 2026filed 1 May 2026 | EBS Emergent BioSolutionsBiotechnology | SEC FORM 4 Code A | —100,111 at $0.00 | filing |
| 5 Mar 2026filed 5 Mar 2026 | EBS Emergent BioSolutionsBiotechnology | SEC FORM 4 Code F | $80K9,493 at $8.44 | filing |
| 5 Mar 2026filed 5 Mar 2026 | EBS Emergent BioSolutionsBiotechnology | SEC FORM 4 Code F | $80K9,493 at $8.44 | filing |
| 3 Mar 2026filed 5 Mar 2026 | EBS Emergent BioSolutionsoption or derivative · Biotechnology | SEC FORM 4 Code A | —44,834 at $0.00 | filing |
| 3 Mar 2026filed 5 Mar 2026 | EBS Emergent BioSolutionsoption or derivative · Biotechnology | SEC FORM 4 Code A | —44,834 at $0.00 | filing |
| 6 Feb 2026filed 10 Feb 2026 | EBS Emergent BioSolutionsBiotechnology | SEC FORM 4 Code D | $63K5,771 at $10.92 | filing |
| 6 Feb 2026filed 10 Feb 2026 | EBS Emergent BioSolutionsBiotechnology | SEC FORM 4 Code F | $6,880630 at $10.92 | filing |
| 6 Feb 2026filed 10 Feb 2026 | EBS Emergent BioSolutionsBiotechnology | SEC FORM 4 Code D | $63K5,771 at $10.92 | filing |
| 6 Feb 2026filed 10 Feb 2026 | EBS Emergent BioSolutionsBiotechnology | SEC FORM 4 Code F | $6,880630 at $10.92 | filing |
| 11 Nov 2025filed 13 Nov 2025 | EBS Emergent BioSolutionsBiotechnology | SEC FORM 4 Code F | $6,637610 at $10.88 | filing |
| 11 Jul 2025filed 15 Jul 2025 | EBS Emergent BioSolutionsBiotechnology | SEC FORM 4 Code F | $31K4,263 at $7.36 | filing |
| 8 Jun 2025filed 10 Jun 2025 | EBS Emergent BioSolutionsBiotechnology | SEC FORM 4 Code F | $7,7371,167 at $6.63 | filing |
| 7 Apr 2025filed 9 Apr 2025 | EBS Emergent BioSolutionsBiotechnology | SEC FORM 4 Code F | $2,491561 at $4.44 | filing |
| 6 Mar 2025filed 9 Apr 2025 | EBS Emergent BioSolutionsBiotechnology | SEC FORM 4 Code A | —62,500 at $0.00 | filing |
| 6 Mar 2025filed 10 Mar 2025 | EBS Emergent BioSolutionsoption or derivative · Biotechnology | SEC FORM 4 Code A | —62,500 at $0.00 | filing |
| 6 Mar 2025filed 10 Mar 2025 | EBS Emergent BioSolutionsBiotechnology | SEC FORM 4 Code A | —62,500 at $0.00 | filing |
| 5 Mar 2025filed 7 Mar 2025 | EBS Emergent BioSolutionsBiotechnology | SEC FORM 4 Code F | $1,694292 at $5.80 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.